Implementing Cost Reduction Strategies for HuMab Manufacturing Processes

View PDF

humab-story2-lrgTo keep up with increasing clinical demand, antibody manufacturers are forced to adapt their methods to increase production without increasing costs. In this informative paper, Dr. Arunakumari Alahari, Senior Director of Process Development at Medarex, Inc., discusses several processes that can be implemented to reduce costs of manufacturing, including:

  • Perfusion Process for Cell Line Amplification
  • Perfusion Process for Cell Bank Preparation
  • CHO Production Using In-House Medium
  • High Capacity Non-Protein A Purification Processes

Read the full article to discover how innovative technologies and effective regulatory strategies can accelerate process development and reduce time-to-market.

Leave a Reply